Pfizer (PFE)
$28.05
0.35 (1.26%)
PFE Stock Quote Delayed 30 Minutes
Dow Jones Today: Stocks Pinched by Jobs Disappointment
The December jobs report was't as strong as economists expected and that triggered some modest selling on Wall Street to close the week.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
157.27B
PE Ratio
-561.00
EPS
-0.05
Volume (Avg. Vol.)
17.27M
Day's Range
$27.67 - $28.09
52-Week Range
$25.20 - $37.80
Dividend & Yield
$1.64 (5.85%)
PFE Stock Predictions, Articles, and Pfizer News
After Lackluster 2019, Pfizer Stock Could Rebound in 2020
Wall Street has discounted Pfizer's divestiture plans. But spinning off off-patent drugs could improve the valuation of PFE stock.
Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow
The lagging healthcare sector has been building momentum and that boosted the Dow Jones Industrial Average today.
3 Big Stock Charts for Friday: Snap, Pfizer and Splunk
Friday's 3 big stock charts highlight 3 names looking for help from a market at all-time highs.
Should Investors Buy Pfizer Stock Before Next Year’s Huge Shake Up?
There's a strong case for investing in Pfizer stock. With a great deal of uncertainty in the near-term, however, some patience with PFE stock may be required.
Why This Just Might Be the Biggest Week for CARA Stock
Cara stock is up ahead of its presentations at Kidney Week 2019. Unless it reports bad news, Cara Therapeutics looks ready to run.
Stock Market Today: Earnings, Fed Drive New Highs
The S&P 500 hit another new all-time high on Tuesday. Here's what happened in the stock market today to get it there.
5 Top Stock Trades for Wednesday: GM, AAPL, SHOP, GRUB, PFE
GrubHub, Shopify, Apple, Pfizer and General Motors were our top stock trades from Tuesday. Here's a look at the charts.
Tuesday’s Vital Data: Fitbit, Pfizer and Twitter
Options trading was hot in Fitbit, Pfizer, and Twitter on Monday. Here’s what the data suggests moving forward.
Akcea Therapeutics News: AKCA Stock Rockets on Pfizer Licensing Deal
Akcea Therapeutics (AKCA) stock is flying high on Monday following news of a $250 million deal with Pfizer (NYSE:PFE) for licensing rights.
Trade of the Day: Pfizer Stock Is Flashing Attractive Buy Signals
PFE stock recently dropped 20% following the company's latest earnings report. As a result, Pfizer has reached extreme oversold readings that could lead to a pop in the stock.
